News
Dapagliflozin significantly reduced the risk of all-cause mortality or worsening heart failure by 28% in high-risk patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback